2009
Averting epidemics of extensively drug-resistant tuberculosis
Basu S, Friedland GH, Medlock J, Andrews JR, Shah NS, Gandhi NR, Moll A, Moodley P, Sturm AW, Galvani AP. Averting epidemics of extensively drug-resistant tuberculosis. Proceedings Of The National Academy Of Sciences Of The United States Of America 2009, 106: 7672-7677. PMID: 19365076, PMCID: PMC2678614, DOI: 10.1073/pnas.0812472106.Peer-Reviewed Original ResearchConceptsDrug-resistant tuberculosisXDR-TBXDR-TB epidemicDrug susceptibility testingCommunity-based EpidemicsCommunity-based programsEffective reproductive numberTertiary hospitalTB epidemicDisease presentationPublic health conditionsCase findingTransmission clustersDiagnostic approachHealth conditionsSouth African communityOngoing transmissionTransmission dynamicsTherapyTuberculosisEpidemicReproductive numberTBKwaZulu-Natal ProvinceHospital
2007
Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Implications for the HIV Epidemic and Antiretroviral Therapy Rollout in South Africa
Andrews JR, Shah NS, Gandhi N, Moll T, Friedland G. Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Implications for the HIV Epidemic and Antiretroviral Therapy Rollout in South Africa. The Journal Of Infectious Diseases 2007, 196: s482-s490. PMID: 18181698, DOI: 10.1086/521121.Peer-Reviewed Original ResearchConceptsDrug-resistant tuberculosisMDR-TBHIV epidemicXDR-TBDrug-resistant (XDR) TBMultidrug-resistant (MDR) TBMDR-TB treatment programmeTB treatment success rateHuman immunodeficiency virus (HIV) infectionAntiretroviral therapy rolloutXDR-TB epidemicImmunodeficiency virus infectionTreatment success rateDrug resistance surveillanceDrug resistance testingPublic health challengeAirborne infection controlPublic health infrastructureHIV programsMultidrug-ResistantHigh prevalenceVirus infectionInfection controlTreatment programTuberculosis